Perspective Therapeutics (CATX) Current Leases (2019 - 2026)

Perspective Therapeutics has disclosed Current Leases across 8 years of filings, most recently posting $1.1 million for Q2 2026.

• In Q2 2026, Current Leases rose 29.52% year-over-year to $1.1 million; the TTM figure through Jun 2026 stood at $1.1 million (up 29.52% YoY), while the FY2025 annual figure was $623000.0, down 34.9% from the prior year.
• Current Leases came in at $1.1 million for Q2 2026 at Perspective Therapeutics, up from $1.1 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.1 million in Q2 2026 to a low of $46000.0 in Q4 2023.
• Average Current Leases over 5 years is $571352.9, with a median of $623000.0 recorded in 2025.
• The largest YoY upside for Current Leases was 1980.43% in 2024 against a maximum downside of 54.29% in 2024.
• Over 5 years, Current Leases stood at $272000.0 in 2022, then tumbled by 83.09% to $46000.0 in 2023, then jumped by 1980.43% to $957000.0 in 2024, then sank by 34.9% to $623000.0 in 2025, then jumped by 76.08% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $1.1 million in Q2 2026, $1.1 million in Q1 2026, and $623000.0 in Q4 2025.